While it’s now a top source of biopharmaceutical innovation, we believe China’s biotech sector is still in its early stages.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The Subject Expert Committee (SEC) on Vaccines, operating under the Central Drugs Standard Control Organization (CDSCO), has ...

The row between pharma companies and the U.K. government over rebates has intensified, with the Association of the British Pharmaceutical Industry (ABPI) calling up its members to speak on the record, ...

The genomic biomarkers market is experiencing rapid growth, driven by advancements in precision medicine, early disease ...

The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

BTIG analysts upgraded Doximity, Inc. (NYSE:DOCS)’s stock from “Neutral” to “Buy” with the price objective of $80. The ...

In 2018, the FDA began an investigation into nitrosamine impurities in drugs that led to high-profile recalls for heartburn ...

An announcement from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On June 2, 2025, Telomir Pharmaceuticals announced its ...

Instil Bio (TIL) has announced the appointment of Jamie Freedman as Chief Medical Officer.  Jamie Freedman is a Hematologist-Oncologist and a highly experienced biopharmaceutical executive.

India’s domestic pharmaceutical market stood at US$ 42 billion in 2021 and is likely to reach US$ 65 billion by 2024 and further expand to reach US$ 120-130 billion by 2030. India's biotechnology ...

Charlottesville biotech support helps startups like Luminoah and Rivus grow, with the Manning Institute and CvilleBioHub leading the way ...